CERS
CerusยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CERS Profile
Cerus Corporation
A company that develops blood safety systems to inactivate blood-borne pathgens in components intended for transfusion
Healthcare Equipment and Supplies
--
01/30/1997
NASDAQ Stock Exchange
281
12-31
Common stock
1220 Concord Avenue, Suite 600, Concord, California 94520
--
Cerus Corporation, founded in California in 1991 and re-incorporated in Delaware in 1996. The Company is a biomedical products company focused on developing and commercializing the INTERCEPT blood system to enhance blood safety. The Company's INTERCEPT blood system is designed to work with blood components and certain of their derivatives: platelets, plasma, red blood cells and the production of INTERCEPT fibrinogen complex, or IFC, as well as pathogen-reducing plasma, cryoprecipitate reduction.
